Upsher-Smith intros dicyclomine hydrochloride
The drug is used to treat irritable bowel syndrome.
Upsher-Smith is introducing dicyclomine hydrochloride tablets in a dosage strength of 20 mg.
The product is used to treat irritable bowel syndrome.
Upsher-Smith's strategic partnership with CorePharma, a product development and manufacturing company, made the launch possible.
[Read more: Upsher-Smith opens manufacturing facility in Minnesota]
The dicyclomine hydrochloride tablet had a market value of approximately $33 million for the 12 months ending March 2022, according to IQVIA.
[Read more: Upsher-Smith extends fluoxetine product line]